Binding of the Radioligand SIL23 to α-Synuclein Fibrils in Parkinson Disease Brain Tissue Establishes Feasibility and Screening Approaches for Developing a Parkinson Disease Imaging Agent
Table 3
Comparison of Ki values for SIL analogues in assays with recombinant α-syn fibrils versus human PD tissue.